SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael Morrissey, Ph.D., the company’s president and chief executive officer, will present at the upcoming Citi 2011 Global Health Care Conference at 3:30 p.m. EST / 12:30 p.m. PST on Tuesday, March 1, 2011 in New York. Dr. Morrissey will review the latest clinical data for cabozantinib (XL184) in castration-resistant prostate cancer (CRPC), which were presented at the ASCO Genitourinary Cancers Symposium earlier this month, and will discuss the pivotal trial plans and regulatory strategy for the compound in CRPC. He will also discuss the company’s 2011 financial outlook and provide a general business update.
